Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 2
1951 1
1952 1
1954 1
1959 1
1961 2
1962 2
1963 6
1964 2
1970 1
1973 2
1974 2
1977 1
1978 3
1979 2
1981 2
1982 5
1983 2
1984 3
1985 4
1986 10
1987 12
1988 12
1989 8
1990 12
1991 7
1992 10
1993 6
1994 11
1995 15
1996 13
1997 24
1998 19
1999 18
2000 18
2001 13
2002 5
2003 12
2004 8
2005 13
2006 12
2007 4
2008 3
2009 8
2010 10
2011 6
2012 4
2013 3
2014 1
2015 4
2016 3
2017 5
2018 11
2019 14
2020 7
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 10586004

380 results
Results by year
Filters applied: . Clear all
Page 1
Acellular vaccines containing reduced quantities of pertussis antigens as a booster in adolescents.
Tran Minh NN, He Q, Ramalho A, Kaufhold A, Viljanen MK, Arvilommi H, Mertsola J. Tran Minh NN, et al. Pediatrics. 1999 Dec;104(6):e70. doi: 10.1542/peds.104.6.e70. Pediatrics. 1999. PMID: 10586004 Clinical Trial.
Reduced-antigen, combined diphtheria, tetanus and acellular pertussis vaccine, adsorbed (Boostrix®): a review of its properties and use as a single-dose booster immunization.
McCormack PL. McCormack PL. Drugs. 2012 Sep 10;72(13):1765-91. doi: 10.2165/11209630-000000000-00000. Drugs. 2012. PMID: 22931522 Review.
Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
Grimprel E, von Sonnenburg F, Sänger R, Abitbol V, Wolter JM, Schuerman LM. Grimprel E, et al. Vaccine. 2005 May 25;23(28):3657-67. doi: 10.1016/j.vaccine.2005.02.013. Vaccine. 2005. PMID: 15882526 Clinical Trial.
Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents.
Pichichero ME, Blatter MM, Kennedy WA, Hedrick J, Descamps D, Friedland LR. Pichichero ME, et al. Pediatrics. 2006 Apr;117(4):1084-93. doi: 10.1542/peds.2005-1759. Pediatrics. 2006. PMID: 16585302 Clinical Trial.
Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4-7-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age.
Dagan R, Igbaria K, Piglansky L, Van Brusteghem F, Melot V, Kaufhold A. Dagan R, et al. Vaccine. 1999 Jun 4;17(20-21):2620-7. doi: 10.1016/s0264-410x(99)00065-1. Vaccine. 1999. PMID: 10418911 Clinical Trial.
Repeated administration of a reduced-antigen-content diphtheria-tetanus-acellular pertussis and poliomyelitis vaccine (dTpa-IPV; Boostrix™ IPV).
Knuf M, Vetter V, Celzo F, Ramakrishnan G, Van Der Meeren O, Jacquet JM. Knuf M, et al. Hum Vaccin. 2010 Jul;6(7):554-61. doi: 10.4161/hv.6.7.11760. Hum Vaccin. 2010. PMID: 20448468 Clinical Trial.
Comparison of a three-component acellular pertussis vaccine with a whole-cell pertussis vaccine in 15- through 20-month-old infants.
Bernstein HH, Rothstein EP, Reisinger KS, Blatter MM, Arbeter AM, Fontana ME, Jacobs JM, Long SS, Rathfon H, Crayne O, et al. Bernstein HH, et al. Pediatrics. 1994 Apr;93(4):656-9. Pediatrics. 1994. PMID: 8134224 Clinical Trial.
Comparative reactogenicity and immunogenicity of booster doses of diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine and diphtheria-tetanus-inactivated poliovirus vaccine in preadolescents.
Bégué PC, Grimprel EM, Giovannangeli MD, Abitbol VI. Bégué PC, et al. Pediatr Infect Dis J. 1998 Sep;17(9):804-9. doi: 10.1097/00006454-199809000-00011. Pediatr Infect Dis J. 1998. PMID: 9779766 Clinical Trial.
Immunogenicity and reactogenicity of a decennial booster dose of a combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and inactivated poliovirus booster vaccine (dTpa-IPV) in healthy adults.
Kovac M, Rathi N, Kuriyakose S, Hardt K, Schwarz TF. Kovac M, et al. Vaccine. 2015 May 21;33(22):2594-601. doi: 10.1016/j.vaccine.2015.03.104. Epub 2015 Apr 14. Vaccine. 2015. PMID: 25882172 Free article. Clinical Trial.
A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.
Pichichero ME, Deloria MA, Rennels MB, Anderson EL, Edwards KM, Decker MD, Englund JA, Steinhoff MC, Deforest A, Meade BD. Pichichero ME, et al. Pediatrics. 1997 Nov;100(5):772-88. doi: 10.1542/peds.100.5.772. Pediatrics. 1997. PMID: 9346976 Clinical Trial.
380 results
Jump to page
Feedback